MIAMI, July 20, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a biopharmaceutical company focused on urology and oncology, today announced that the company has initiated the subject ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results